i-SENS

099190 · KOSDAQ · Health Care · SMALL CAP

Provisional Q2 2026 results.

i-SENS filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$60.4M (+15.2% year on year), operating profit of US$4.29M (+274.1% year on year) and net income of US$2.37M (+341.9% year on year).

Earnings(Operating results (consolidated) (preliminary) (fair disclosure))· FILED 2026-07-27· RCEPT 20260727900146

US$60.4MRevenue
+15.2%Revenue vs a year earlier
US$4.29MOperating profit

Converted at 1 USD ≈ ₩1,464.44 (filing-date rate, 2026-07-27 close)

What happened

i-SENS filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$60.4M (+15.2% year on year), operating profit of US$4.29M (+274.1% year on year) and net income of US$2.37M (+341.9% year on year).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$60.4M
Revenue vs a year earlier+15.2%
Operating profitUS$4.29M
Net incomeUS$2.37M
PeriodQ2 2026 (consolidated)
Filed2026-07-27, Operating results (consolidated) (preliminary) (fair disclosure)
SourceDART rcept 20260727900146 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-27 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.